Grants and Contracts per year
Personal profile
Research Interests
Obesity-associated complications (chronic inflammation, insulin resistance, NAFLD), kidney injury and cancer.
Education/Academic qualification
Doctor of Philosophy, Peking Medical Col.
1997
Doctor of Medicine, Shanxi Medical College
1991
Fingerprint
- 1 Similar Profiles
Network
-
Role of SMPDL3B in Obesity-Associated Non-Alcoholic Fatty Liver Disease
Wang, S., COHEN, D., Lee, E., Nikolova-Karakashian, M. & Tong, S.
National Institute Diabetes & Digestive & Kidney
7/1/22 → 4/30/27
Project: Research project
-
COBRE: Center of Research on Obesity and Cardiovascular Disease Core D: Energy Balance
Wang, S., Cassis, L., Katz, W. & Zhou, C.
National Institute of General Medical Sciences
8/1/18 → 7/31/23
Project: Research project
-
COBRE: Center of Research on Obesity and Cardiovascular Disease
Cassis, L., Finlin, B., Katz, W., Pearson, K., Stanley, S., Thompson, K., Wang, S., Morris, A. & Zhou, C.
National Institute of General Medical Sciences
8/1/18 → 7/31/23
Project: Research project
-
COBRE Pilot: Endogenous Ligand for NR4A1 Orphan Nuclear Receptor and Systemic Metabolism
National Institute of General Medical Sciences
8/1/18 → 7/31/23
Project: Research project
-
Targeting Brown Fat for Aging-related Obesity and Type 2 Diabetes
Washington University in St. Louis
2/23/13 → 11/30/23
Project: Research project
-
Anti-CD47 antibody treatment attenuates liver inflammation and fibrosis in experimental non-alcoholic steatohepatitis models
Gwag, T., Ma, E., Zhou, C. & Wang, S., Apr 2022, In: Liver International. 42, 4, p. 829-841 13 p.Research output: Contribution to journal › Article › peer-review
6 Scopus citations -
Absence of CD47 maintains brown fat thermogenic capacity and protects mice from aging-related obesity and metabolic disorder
Li, D., Gwag, T. & Wang, S., Oct 20 2021, In: Biochemical and Biophysical Research Communications. 575, p. 14-19 6 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Erratum: Non-nucleoside reverse transcriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia and hepatic steatosis (Journal of Hepatology (2019) 70(5) (930–940), (S0168827819300297), (10.1016/j.jhep.2018.12.038))
Gwag, T., Meng, Z., Sui, Y., Helsley, R. N., Park, S. H., Wang, S., Greenberg, R. N. & Zhou, C., Apr 2021, In: Journal of Hepatology. 74, 4, p. 1003-1004 2 p.Research output: Contribution to journal › Comment/debate
Open Access -
Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease
Gwag, T., Reddy Mooli, R. G., Li, D., Lee, S., Lee, E. Y. & Wang, S., Feb 2021, In: JHEP Reports. 3, 1, 100193.Research output: Contribution to journal › Article › peer-review
Open Access13 Scopus citations -
CD47 differentially regulates white and brown fat function
Norman-Burgdolf, H., Li, D., Sullivan, P. & Wang, S., Dec 16 2020, In: Biology Open. 9, 12, bio056747.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations